Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study investigated the relationship of obesity, insulin resistance, inflammation and angiogenesis with cancer progression and survival in a colorectal cancer cohort. METHODS: Clinical and pathological data, along with anthropometric and follow-up data, were collected from 344 consecutive colorectal cancer patients. Serum samples at diagnosis were analysed by immunoassay for adiponectin, C-reactive protein (CRP), vascular endothelial growth factor-A (VEGF-A), angiopoietin-2 (Ang-2), insulin-like growth factor-1 (IGF-1), insulin and C-peptide. RESULTS: Serum Ang-2 and VEGF-A levels increased with tumour T stage (P=0.007 and P=0.025, respectively) and N stage (P=0.02 and P=0.03, respectively), and correlated with CRP levels (r=0.43, P<0.001 and r=0.23, P<0.001, respectively). Angiopoietin-2 correlated with C-peptide (r=0.14, P=0.007) and VEGF-A with IGF-1 in males (r=0.25, P=0.001). Kaplan-Meier analysis showed that patients with high serum levels of CRP and Ang-2 had significantly reduced survival (both P≤0.001). After adjusting for tumour stage and age, Ang-2 remained a significant predictor of survival. The CRP levels were inversely associated with survival in American Joint Committee on Cancer stage II patients (P=0.038), suggesting that CRP could be used to support treatment decisions in this subgroup. Serum markers and anthropometric measures of obesity correlated with each other, but not with survival. CONCLUSION: Our study supports the concept that obesity-related inflammation, rather than obesity itself, is associated with colorectal cancer progression and survival. The study confirms serum Ang-2 as a predictive marker for outcome of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Experimental and epidemiological studies support the concept that chronic inflammation has cancer-promoting properties (Mantovani et al, 2008; Porta et al, 2009).”
BackgroundAmerican Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“While total serum levels of adiponectin and IGF-1 were measured, our assay system was unable to distinguish high molecular weight multimers of adiponectin, which represent the most biologically active form (Kadowaki et al, 2006), and may have better predictive value.”
MethodInflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 1×
“It is now well established that obesity is characterised by chronic inflammation (Greenberg and Obin, 2006; Park et al, 2010), with associated increases of CRP, interleukin-6 (IL-6) and plasminogen activator inhibitor (Dandona et al, 2004).”
BackgroundPark, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 2×
“Recent in vivo data in dietary and genetically obese mouse models demonstrated obesityrelated liver inflammation and subsequent release of IL-6 and TNFa (Park et al, 2010).”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 3×
“…of obesity and metabolic syndrome as risk factors for colorectal cancer development, data are equivocal for their effects on colorectal cancer progression and outcome (Trevisan et al, 2001; Dignam et al, 2006; Reeves et al, 2007; Meyerhardt et al, 2008; Moon et al, 2008; Wolpin et al, 2009).”
BackgroundResultInfluential
Research works printed but not linked: 1
- Ministry of Health (2007) Diabetes surveillance: population-based estimates and projections for New Zealand, 2001–2011: Public Health Intelligence Occasional Bulletin No. 46. Ministry of Health: Wellington. http://www.moh.govt.nz/moh.nsf/indexmh/diabetes-suveillance-population-estimates-projections-2001-2011, accessed 21 April 2010
Cited by
Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., & Lorton, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143080 · Cited by 274
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197
Microparticles in Angiogenesis: Therapeutic Potential
Martinez, M. C., & Andriantsitohaina, R. (2011) · Circulation Research · doi:10.1161/circresaha.110.233049 · Cited by 178
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Wei, X.-L., Wang, F.-H., Zhang, D.-S., Qiu, M.-Z., Ren, C., Jin, Y., Zhou, Y.-X., Wang, D.-S., He, M.-M., Bai, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1379-6 · Cited by 159
Metadata
- Authors
- Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J.
- Affiliations
- University of Otago (NZ)
- Christchurch Hospital (NZ)
- Corresponding author
- Currie, M J
- Venue
- British Journal of Cancer
- Published
- 2010-11-16
- Volume
- 104
- Issue
- 1
- Pages
- 51-59
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3039823
- OpenAlex
- W1987497125
- Cited by
- 78
- References
- 55
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 6
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tertiary Education Commission
- University of Otago
- Cancer Society of New Zealand
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- colorectal cancer, angiopoietin-2, C-reactive protein, obesity, insulin resistance, inflammation, angiogenesis, VEGF-A, insulin-like growth factor I, adiponectin, cancer survival, prognostic factors, tumor stage, obesity-associated inflammation
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, C-Peptide, C-Reactive Protein, Enzyme-Linked Immunosorbent Assay, Female, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Middle Aged, Obesity, Prospective Studies, Colorectal Neoplasms, Biomarkers, Body Mass Index, Survival Rate, Treatment Outcome, Vascular Endothelial Growth Factor A, Angiopoietin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. https://app.cochat.ai/papers/10.1038/sj.bjc.6606005
- The paper
- Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011). Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6606005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.